Warren Buffett Is No Longer Berkshire's Chairman. Here’s Why I'm Buying the Stock Anyway.

Warren Buffett stepped down immediately as Berkshire Hathaway executive chairman, becoming chairman emeritus; Howard Buffett succeeds him as chairman while Greg Abel remains CEO and capital allocator. The article argues the transition was largely priced in, noting Berkshire shares barely moved and had already fallen from an all-time high reached before Buffett announced his CEO retirement in May 2025. Abel ended 14 consecutive quarters of net equity sales in Q2, increased buybacks to their highest level in five years, and acquired a beaten-down homebuilder, supporting a constructive view of Berkshire's post-Buffett capital deployment.

Analysis

The relevant repricing question is not succession optics but whether BRK's historically conservative capital-allocation discount narrows under Abel. A sustained shift from cash accumulation toward repurchases and acquisitions can lift per-share intrinsic-value compounding, but only if deployed capital earns above Berkshire's opportunity cost; a large acquisition at a cycle peak would instead expose the stock to conglomerate-style multiple compression. The article's favorable assessment of deployment is promotional rather than independently sufficient evidence of incremental ROIC.

Near term, BRK.A/BRK.B should trade on evidence that operating managers retain underwriting discipline at GEICO/BNSF and that Abel's capital allocation is not merely more active. The 1-3 month catalyst path is quarterly disclosure of repurchase pace, cash balances, and acquisition terms; the 6-18 month test is normalized insurance float profitability, railroad margins, and look-through earnings growth relative to the S&P 500. The succession removes a residual key-person overhang, but it also eliminates the market's confidence that a major equity purchase signals Buffett's valuation judgment.

Second-order, a more acquisitive Berkshire raises the strategic bid floor for mid-cap industrial, utility, and housing-adjacent assets, while competing private-equity buyers could face a better-capitalized bidder with no refinancing constraint. That effect is likely modest until an announced transaction establishes Abel's valuation discipline. NFLX and NVDA are not read-throughs to this development; treating the article's promotional references as investable signals would be noise.

Key Decisions for Investors

• Maintain or initiate a modest long BRK.B rather than BRK.A for liquidity, scaled over 1-3 months; thesis is a gradual governance-risk discount reduction, not an event-driven upside. Reassess if the stock materially outperforms the S&P 500 before evidence of higher per-share operating earnings or accretive deployment.
• Use the next earnings release as the decision point: add only if repurchases remain meaningful while cash declines through clearly accretive acquisitions or operating earnings accelerate. Do not extrapolate a single quarter of deployment without purchase-price and ROIC evidence.
• Pair expression for diversified equity exposure: long BRK.B / short SPY only after BRK's relative performance breaks higher on results, targeting a 6-12 month horizon. Exit on deterioration in insurance combined ratio, BNSF margin pressure, or an acquisition that increases leverage without a credible return case.
• Set an M&A watchlist in industrials, regulated utilities, and homebuilding-adjacent companies rather than front-running targets; actionable long positions require a named target, valuation discount, and confirmation that Berkshire is a plausible buyer.